Showing results (461-470 of 1,784) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|February 28, 2016
A Case of Acrodermatitis Continua of Hallopeau Following Chronic Pustular CheilitisMariachiara Arisi, Maria Teresa Rossi, Raffaella Sala, et al.
Dermatology and Therapy|February 21, 2025
Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life StudyLuca Potestio, Fabrizio Martora, Flavia Raia, et al.
Dermatology and Therapy|February 5, 2025
Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 MonthsDiamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, et al.
Dermatology and Therapy|February 17, 2025
Patient Disease Characteristics and Treatment Patterns in Mild-Moderate Psoriasis: Results from Real-World Clinical Practice in the United States (PROSPECT Study)Emily J Goddard, James M Haughton, James E Lucas, et al.
Dermatology and Therapy|January 3, 2025
Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg PreparationKatharina Hogrefe, Julia K Winkler, Alexander H Enk
Dermatology and Therapy|January 3, 2025
Hormonal Therapies for Acne: A Comprehensive Update for DermatologistsCourtney A Smith, Emily Gosnell, Turkan Banu Karatas, et al.
Dermatology and Therapy|November 24, 2024
Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar LinesChih-Hung Lee, Chien-Chih Ou, Tim-Mo Chen
Dermatology and Therapy|December 21, 2024
Forensic Dermatology Expert Analytical Report: A New Frontier of Forensic MedicinePhilip R Cohen, Lerah Sutton
Dermatology and Therapy|November 22, 2024
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled TrialsJoseph F Merola, Alice B Gottlieb, Andreas Pinter, et al.
Dermatology and Therapy|November 22, 2024
A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque PsoriasisBurhan Engin, Müge Güler Özden, Özge Sevil Karstarlı Bakay, et al.
Pageof 179